Search Results - "Farrelly, Angela M"
-
1
Targeting the PI3K and MAPK pathways to improve response to HER2-targeted therapies in HER2-positive gastric cancer
Published in Journal of translational medicine (01-05-2021)“…Aberrant PI3K signalling is implicated in trastuzumab resistance in HER2-positive gastric cancer (GC). The role of PI3K or MEK inhibitors in sensitising…”
Get full text
Journal Article -
2
Design, synthesis and evaluation of novel 2,2-dimethyl-2,3-dihydroquinolin-4(1H)-one based chalcones as cytotoxic agents
Published in Heliyon (01-09-2018)“…We designed and synthesised a series of novel chalcones, incorporating the heterocyclic framework of 2,2-dimethyl-2,3-dihydro-4(1H)-quinolinone, which was…”
Get full text
Journal Article -
3
Chromosomal copy number and mutational status are required to authenticate ovarian cancer cell lines as appropriate cell models
Published in Molecular biology reports (01-12-2024)“…Background The mutational status of ovarian cancer cell line IGROV-1 is inconsistent across the literature, suggestive of multiple clonal populations of the…”
Get full text
Journal Article -
4
Proteomic time course of breast cancer cells highlights enhanced sensitivity to Stat3 and Src inhibitors prior to endocrine resistance development
Published in Cancer gene therapy (01-02-2023)“…To prevent the development of endocrine-resistant breast cancer, additional targeted therapies are increasingly being trialled in combination with endocrine…”
Get full text
Journal Article -
5
BRCA mutations lead to XIAP overexpression and sensitise ovarian cancer to inhibitor of apoptosis (IAP) family inhibitors
Published in British journal of cancer (01-08-2022)“…Background We tested the hypothesis that inhibitor of apoptosis family (IAP) proteins may be altered in BRCA1 -mutated ovarian cancers and that could affect…”
Get full text
Journal Article -
6
Combined Targeted Resequencing of Cytosine DNA Methylation and Mutations of DNA Repair Genes with Potential Use for Poly(ADP-Ribose) Polymerase 1 Inhibitor Sensitivity Testing
Published in The Journal of molecular diagnostics : JMD (01-03-2019)“…Current molecular tumor diagnostics encompass panel sequencing to detect mutations, copy number alterations, and rearrangements. However, tumor suppressor…”
Get full text
Journal Article -
7
AMP-activated Protein Kinase Mediates Apoptosis in Response to Bioenergetic Stress through Activation of the Pro-apoptotic Bcl-2 Homology Domain-3-only Protein BMF
Published in The Journal of biological chemistry (12-11-2010)“…Heterozygous loss-of-function mutations in the hepatocyte nuclear factor 1A (HNF1A) gene result in the pathogenesis of maturity-onset diabetes-of-the-young…”
Get full text
Journal Article -
8
INS-1 Cells Undergoing Caspase-Dependent Apoptosis Enhance the Regenerative Capacity of Neighboring Cells
Published in Diabetes (New York, N.Y.) (01-11-2010)“…In diabetes, β-cell mass is not static but in a constant process of cell death and renewal. Inactivating mutations in transcription factor 1 (tcf-1)/hepatocyte…”
Get full text
Journal Article -
9
Bone Morphogenetic Protein 3 Controls Insulin Gene Expression and Is Down-regulated in INS-1 Cells Inducibly Expressing a Hepatocyte Nuclear Factor 1A–Maturity-onset Diabetes of the Young Mutation
Published in The Journal of biological chemistry (22-07-2011)“…Inactivating mutations in the transcription factor hepatocyte nuclear factor (HNF) 1A cause HNF1A–maturity-onset diabetes of the young (HNF1A-MODY), the most…”
Get full text
Journal Article -
10
Rapamycin protects against dominant negative-HNF1A-induced apoptosis in INS-1 cells
Published in Apoptosis (London) (01-11-2011)“…HNF1A-maturity onset diabetes of the young (HNF1A-MODY) is caused by mutations in Hnf1a gene encoding the transcription factor hepatocyte nuclear factor 1alpha…”
Get full text
Journal Article -
11
Chemotactic, mitogenic, and angiogenic actions of UTP on vascular endothelial cells
Published in The American journal of physiology (01-03-1999)“…Endothelial cells express receptors for ATP and UTP, and both UTP and ATP elicit endothelial release of vasoactive compounds such as prostacyclin and nitric…”
Get full text
Journal Article -
12
Abstract P1-19-24: A phase Ib trial of copanlisib in combination with trastuzumab in pretreated recurrent or metastatic HER2-positive breast cancer “PantHER”
Published in Cancer research (Chicago, Ill.) (15-02-2020)“…Background Activation of the phosphoinositide -3 kinase (PI3K) pathway is a resistance mechanism to anti-HER2 targeted therapy. This trial was conducted to…”
Get full text
Journal Article -
13
Cloning, expression and function of Kv11.1 variants in the human jejunum
Published 01-01-2004“…This thesis investigates the hypothesis that the voltage dependent potassium channel Kv11.1 is present in the human jejunum and significantly contributes to…”
Get full text
Dissertation